Related Experiment Video
Updated: Mar 26, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in aged patients
Zhong-Hai Wei1, Jie Song1, Lian Wang1
1Department of Cardiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Insights
Interventional therapy is effective and safe for elderly patients with unprotected left main coronary artery lesions. Left ventricular ejection fraction (LVEF) predicts cardiac death, while LVEF and estimated glomerular filtration rate (eGFR) predict major adverse cardiac events.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Cardiology
Background:
- Unprotected left main coronary artery (UPLM) lesions pose significant risks in elderly patients.
- Assessing therapeutic options for UPLM lesions in older individuals is crucial for improving outcomes.
Purpose of the Study:
- To evaluate the therapeutic efficacy and safety of interventional therapy for UPLM lesions in patients over 60 years old.
- To identify predictors of cardiac death and major adverse cardiac events (MACE) in this patient cohort.
Main Methods:
- A retrospective analysis of 61 patients over 60 undergoing UPLM interventional therapy from January 2012 to November 2013.
- Follow-up averaged 14.6 months via telephone or outpatient visits to assess clinical outcomes.
- Multivariate regression analysis (COX proportional hazards model) was used to identify independent predictors.
Main Results:
- The study included 61 patients with an average age of 73.9 years, average LVEF of 47.7%, and median eGFR of 52 mL/min/1.73 mm(2).
- The 30-day cardiac death rate was 6.6%, and the one-year MACE rate was 32.5%.
- Left ventricular ejection fraction (LVEF) predicted 30-day cardiac death, while LVEF and estimated glomerular filtration rate (eGFR) predicted one-year MACE.
Conclusions:
- Interventional therapy for UPLM lesions is a safe and effective treatment option for aged patients.
- LVEF is a significant predictor of early cardiac death, and both LVEF and eGFR are important predictors of long-term MACE in this population.
Objective:
To assesse the therapeutic effect of interventional therapy in aged patients with unprotected left main coronary artery (UPLM) lesions.
Methods:
A total of 61 patients who were over 60 years and accepted interventional therapy of UPLM from January 2012 to November 2013 in our hospital were followed up for average 14.6 months by telephone call or outpatient visits. We analyzed the clinical features data of the interventional therapy and assessed the factors that likely influenced the clinical prognosis.
Results:
The average age of the 61 patients was 73.9 years. The average left ventricular ejection fraction (LVEF) was 47.7%. The median of the estimated glomerular filtration rate (eGFR) was 52 mL/min per 1.73 mm(2). The average SYNTAX score was 27.4 and the median of stent length was 36 mm. The cumulative incidence of cardiac death at 30 days and major adverse cardiac events (MACE) after one year was 6.6% and 32.5% estimated by Kaplan-Meier plots respectively. No severe hemorrhagic complications were observed during follow-up period. On multivariate regression analysis with a COX proportional hazards model, LVEF was an independent predictor of cardiac death at 30 days [Hazard ratio (HR): 0.7, P = 0.01]. As for MACE after one year, LVEF and eGFR were both independent predictors (HR: 0.91, P = 0.06 for LVEF, HR: 0.03, P = 0.097 for eGFR).
Conclusions:
The interventional therapy for UPLM was effective and safe in aged patients. LVEF was the only predictor of cardiac death at 30 days, while LVEF and eGFR were both independent predictors of MACE after one year.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures